Skip to main content

Deborah A. Daccord

Member

[email protected]

+1.617.348.4716

Follow:
Share:

Deborah is a nationally recognized leader in health industry transactions, with nearly 30 years of experience running complex mergers and acquisitions, joint ventures, strategic alliances, financing and contracting for health care providers and investors across the United States. At any given time, Deborah is engaged in leading teams of the firm’s transactional and regulatory lawyers on several large-scale deals. Her clients value her strategic thinking as well as her project management skills, from both a deal closure and cost perspective. Deborah also provides general counseling and strategic planning for both nonprofit and for-profit health care providers. She is consistently recognized by her peers and leading publications for excellence in health care law.

Deborah’s recent health industry merger and acquisition activity includes acquisitions and sales, joint ventures, and strategic affiliations totaling over one billion dollars. Her clients span the health care spectrum, including providers of ambulatory surgery services, micro-hospital development and management services, physician networks, kidney care services, vision care services, radiology and teleradiology services, home care services, fertility services, value based care, and behavioral health services (including substance use disorder treatment). Deborah has extensive project management experience, and provides deal structuring, general counseling, regulatory advice, and strategic planning for both nonprofit and for-profit health care providers.

Deborah is a Member in the firm's Health Law Practice. She is also a member of the firm's Health Reform Working Group and has served on the Policy Committee.

Deborah is also a certified Pilates instructor.

Deborah is a nationally recognized leader in health industry transactions, with nearly 30 years of experience running complex mergers and acquisitions, joint ventures, strategic alliances, financing and contracting for health care providers and investors across the United States. At any given time, Deborah is engaged in leading teams of the firm’s transactional and regulatory lawyers on several large-scale deals. Her clients value her strategic thinking as well as her project management skills, from both a deal closure and cost perspective. Deborah also provides general counseling and strategic planning for both nonprofit and for-profit health care providers. She is consistently recognized by her peers and leading publications for excellence in health care law.

Experience

  • Represented a Fortune 500 company that is a leading provider of kidney care services in hundreds of acquisitions, sales, and strategic joint ventures nationwide, including a 50-clinic partial divestiture and strategic joint venture with a leading health system
  • Represented a private equity backed radiology services provider in multiple physician practice and imaging center acquisitions and joint ventures
  • Represented multiple clients in developing value-based care solutions
  • Represented a Northeast regional provider of comprehensive substance use disorder treatment, including acute in-patient, outpatient and long-term residency programs in a cash and roll-over equity sale to a national strategic buyer
  • Represented a provider of geriatric behavioral health services in a cash and roll-over equity sale to a private equity buyer
  • Represented a national provider of physician staffing services in the spin-off and sale of its home health care business and multi-specialty physician practice
  • Represented a leading provider of fertility management services in the development of a cross-border nutraceutical joint venture
Read less

viewpoints

As the Mintz Health Law team welcomes the beginning of 2024, many of its members take a moment to reflect on the exciting growth of the Health Law Practice, opportunities to partner with clients on complex legal issues, and the celebration of numerous milestones.
Read more
Health Care Viewpoints Thumbnail

Approved: California Regulations for the Pre-Closing Review of Health Care Transactions Finalized

December 28, 2023 | Blog | By Kathryn Edgerton, Deborah Daccord, Lara Compton

California’s new Office of Health Care Affordability (OHCA) is set to start pre-closing regulatory review of certain health care transactions on January 1, 2024. As further explained in our previous post, subject to certain exceptions, a broad range of health care entities (collectively, Health Care Entities) soon will be subject to potential pre-closing transaction review.
Read more
Health Care Viewpoints Thumbnail
California’s new Office of Health Care Affordability (OHCA) is set to begin advance regulatory review of certain health care transactions beginning January 1, 2024. As further explained in our previous post, subject to certain exceptions, a broad range of health care entities (collectively, Health Care Entities) will soon be subject to potential prospective transaction review. OHCA initially published proposed regulations for the new transaction review process in early August (for more details, see our prior post and podcast).  As further discussed in our previous post, these proposed regulations were revised in October and made available on the OHCA website, with a comment period that ended on October 17, 2023. In response to October’s public comments, OHCA has further revised the proposed regulations (Revised Regulations), which are available here. This time however, OHCA has also provided notice of proposed emergency regulatory action, indicating that this version of the regulations will be submitted to the California Office of Administrative Law (OAL) for approval. Once submitted, the public will have five days to provide comments to the OAL. If the OAL approves the regulations, it will file them with the California Secretary of State and the regulations will become effective as emergency regulations for five years as of the filing date. During this period, OHCA will proceed with regular rulemaking action addressing prospective health care transaction review.
Read more
California’s new Office of Health Care Affordability (OHCA) is set to begin advance regulatory review of certain health care transactions beginning January 1, 2024. As further explained in our previous post, subject to certain exceptions, third party payers and administrators, hospitals, hospital systems, fully integrated delivery systems, pharmacy benefit managers, physician organizations, and other providers (collectively, Health Care Entities) will soon be subject to potential prospective transaction review. OHCA initially published proposed regulations for the new transaction review process in early August (for more details, see our prior post and our podcast). Multiple stakeholders expressed concerns with the proposed regulations during the public comment period, which ended August 31, 2023. In response to these comments, OHCA has published revised proposed regulations (Revised Regulations) allowing for an abbreviated comment period that ends October 17, 2023. The Revised Regulations are available here.
Read more

Health Law Diagnosed – CA Proposes Regs for Pre-Closing Review of Health Care Deals: What You Need to Know

August 21, 2023 | Podcast | By Lara Compton, Deborah Daccord, Bridgette Keller, Daria Niewenhous

Mintz Health Law attorneys discuss regulations recently proposed by California’s newly established Office of Health Care Affordability, which call for advance regulatory review of certain health care entity mergers, acquisitions, affiliations, and other arrangements.
Read more

Health Care Deal Structures: What Will the Deal Look Like?

February 15, 2023 | Blog | By Pamela Polevoy, Deborah Daccord, Cody Keetch

Deal structure is the foundation of a health care transaction. This post offers practical tips and hypothetical case studies for laying the groundwork for a successful health care transaction.
Read more

Mintz Health Law: What We Are Grateful For

January 11, 2023 | Podcast | By Bridgette Keller

Bridgette Keller speaks with the Mintz Health Law team about what they are grateful for as they look back on a year of client service, mentorship, and working together as a team.
Read more

Removing Barriers to Second Chances

January 24, 2022 | Article

Mintz initiated many pro bono projects to combat systemic racism after the murder of George Floyd, including organizing Massachusetts Criminal Offender Record Information sealing clinics with the Lawyers Clearinghouse and conducting research for a Boston-based nonprofit into how housing authorities around the country evaluate applicants with open criminal charges.
Read more
In this episode of the Health Law Diagnosed podcast, members of the Mintz Health Law team discuss their health law–focused 2022 New Year’s resolutions and how they’re helping clients and colleagues navigate the continued challenges and opportunities of the current era.
Read more

363 Sales as a Health Care M&A Tool, Part 2 – Pros and Cons for Buyers and Sellers

September 11, 2020 | Blog | By Deborah Daccord, William Kannel, Tim McKeon

Over the summer, we wrote about why health care companies may want to consider buying assets out of bankruptcy, taking advantage of the Bankruptcy Code Section 363 sale process (a "363 Sale”). We are back with our second post, to provide more detail to the process and discuss some pros and cons of 363 Sales.

As a refresher, a 363 Sale couples a flexible and fast process with ample liability protection for willing buyers. The primary benefit of a 363 Sale is that a buyer can acquire the debtor’s assets free and clear of virtually all liens, claims, and interests burdening the assets and the debtor. And when Section 363 is coupled with the “assumption and assignment” provisions of Section 365 of the Bankruptcy Code, a debtor is able to assign most contracts or leases that a buyer may wish to purchase, including contracts with ironclad anti-assignment language, provided that certain conditions are satisfied. When a target is experiencing severe financial distress, the benefit of acquiring assets “free and clear” is extraordinarily valuable.
Read more
Read less

News & Press

News Thumbnail
Member Deborah Daccord spoke to Modern Healthcare about the state of the market for mental health startups, and what to expect over the next six months.
Press Release Thumbnail
Mintz is pleased to announce that 120 firm attorneys have been recognized as leaders by Best Lawyers® in the 2024 edition of The Best Lawyers in America©.
Press Release Thumbnail
BOSTON –Mintz announced today that 39 of its practices and 81 of its attorneys earned recognition in the 2023 edition of Chambers USA, a guide to the country’s leading law firms.
BOSTON- Mintz is pleased to announce that Member Deborah Daccord has joined CaringBridge’s Board of Directors. Ms. Daccord is among industry leaders in business, technology, health care and the nonprofit sector who support and advise the senior leadership team at CaringBridge in charting the path of the organization in alignment with its mission.
Press Release Thumbnail
Mintz partner and Massachusetts lawyer Julie Korostoff is one of 49 attorneys recognized as “Leaders in Their Fields” by the 2018 Chambers USA: America's Leading Lawyers for Business guide. Chambers named Korostoff a “Recognized Practitioner” in Technology.
Press Release Thumbnail
Best Lawyers named 85 Mintz attorneys to its 2018 list of The Best Lawyers in America. In addition, Mintz attorneys Matthew J. Gardella and Samuel M. Tony Starr were named “Lawyer of the Year” in their respective practice areas.
Mintz is pleased to announce that Deborah Daccord has been recognized by Massachusetts Lawyers Weekly among the 2017 “Top Women of Law.” Ms. Daccord, a Member in the firm’s Health Law Practice, is also Co-chair of the Health Care Transactions Group.
Best Lawyers named 73 Mintz attorneys to its 2017 list of The Best Lawyers in America. Mintz attorneys selected for inclusion in this year’s list span 44 practice areas. 
Firm’s National Healthcare Practice, NY Corporate/M&A and Litigation: General Commercial Among Newest Rankings
The 2015 Chambers USA: America's Leading Lawyers for Business guide names 52 Mintz, Cohn, Ferris, Glovsky and Popeo, P.C.  attorneys as “Leaders in Their Fields.”
Read less

Events & Speaking

Mar
24
2020

Leading Through a Crisis: COVID-19 Executive Idea Exchange Series

As Companies Working with Senior Populations, How are We Leading?

Webinar

Webinar Reference Image
Panelist
Sep
16
2019

WBL Board Program

Breaking Through to the Boardroom: Advice From Non-Traditional Board Candidates

Chicago, IL

Read less

Deborah is a nationally recognized leader in health industry transactions, with nearly 30 years of experience running complex mergers and acquisitions, joint ventures, strategic alliances, financing and contracting for health care providers and investors across the United States. At any given time, Deborah is engaged in leading teams of the firm’s transactional and regulatory lawyers on several large-scale deals. Her clients value her strategic thinking as well as her project management skills, from both a deal closure and cost perspective. Deborah also provides general counseling and strategic planning for both nonprofit and for-profit health care providers. She is consistently recognized by her peers and leading publications for excellence in health care law.

Recognition & Awards

  • BTI Consulting Group: M&A Client Service All-Star (2021)

  • Featured in Best Lawyers in America: Health Care Law (2012 – 2024)

  • Chambers USA: Massachusetts (Band 1) – Healthcare (2007 – 2018); (Band 2) - Healthcare (2019 – 2023)

  • Nightingale’s Healthcare News: Outstanding Healthcare Transaction Lawyer (2009)

  • Greater Boston Chamber of Commerce: Boston's Future Leaders (2006)

  • Harvard Law School Irving Oberman Memorial Award

Read less

Deborah is a nationally recognized leader in health industry transactions, with nearly 30 years of experience running complex mergers and acquisitions, joint ventures, strategic alliances, financing and contracting for health care providers and investors across the United States. At any given time, Deborah is engaged in leading teams of the firm’s transactional and regulatory lawyers on several large-scale deals. Her clients value her strategic thinking as well as her project management skills, from both a deal closure and cost perspective. Deborah also provides general counseling and strategic planning for both nonprofit and for-profit health care providers. She is consistently recognized by her peers and leading publications for excellence in health care law.

Involvement

  • Managing Director, Golden Seeds
  • Board of Trustees, Lasell Village
  • President’s Council and Past Board Chair, Big Sister Association of Greater Boston
  • Founding Member, Women for Whittier
  • Member, Women Business Leaders of the U.S. Health Care Industry Foundation
  • Board of Visitors, Fenway Health
  • Member, American Health Lawyers Association
  • Member, Boston Bar Association
  • Member, The Florida Bar
Read less